JP2011530536A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530536A5
JP2011530536A5 JP2011522288A JP2011522288A JP2011530536A5 JP 2011530536 A5 JP2011530536 A5 JP 2011530536A5 JP 2011522288 A JP2011522288 A JP 2011522288A JP 2011522288 A JP2011522288 A JP 2011522288A JP 2011530536 A5 JP2011530536 A5 JP 2011530536A5
Authority
JP
Japan
Prior art keywords
antibody
fragment
seq
pancreatic cancer
panin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011530536A (ja
JP5919604B2 (ja
Filing date
Publication date
Priority claimed from US12/343,655 external-priority patent/US7993626B2/en
Priority claimed from US12/418,877 external-priority patent/US7906118B2/en
Application filed filed Critical
Priority claimed from PCT/US2009/053192 external-priority patent/WO2010017500A2/en
Publication of JP2011530536A publication Critical patent/JP2011530536A/ja
Publication of JP2011530536A5 publication Critical patent/JP2011530536A5/ja
Application granted granted Critical
Publication of JP5919604B2 publication Critical patent/JP5919604B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522288A 2008-08-08 2009-08-07 抗膵癌抗体 Expired - Fee Related JP5919604B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US8746308P 2008-08-08 2008-08-08
US61/087,463 2008-08-08
US12/343,655 US7993626B2 (en) 2007-01-11 2008-12-24 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US12/343,655 2008-12-24
US14422709P 2009-01-13 2009-01-13
US61/144,227 2009-01-13
US12/418,877 US7906118B2 (en) 2005-04-06 2009-04-06 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
US12/418,877 2009-04-06
PCT/US2009/053192 WO2010017500A2 (en) 2008-08-08 2009-08-07 Anti-pancreatic cancer antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015009665A Division JP2015110618A (ja) 2008-08-08 2015-01-21 抗膵癌抗体

Publications (3)

Publication Number Publication Date
JP2011530536A JP2011530536A (ja) 2011-12-22
JP2011530536A5 true JP2011530536A5 (https=) 2012-08-23
JP5919604B2 JP5919604B2 (ja) 2016-05-18

Family

ID=41664221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011522288A Expired - Fee Related JP5919604B2 (ja) 2008-08-08 2009-08-07 抗膵癌抗体
JP2015009665A Pending JP2015110618A (ja) 2008-08-08 2015-01-21 抗膵癌抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015009665A Pending JP2015110618A (ja) 2008-08-08 2015-01-21 抗膵癌抗体

Country Status (6)

Country Link
EP (1) EP2331134A4 (https=)
JP (2) JP5919604B2 (https=)
CN (1) CN102137681B (https=)
AU (1) AU2009279503B2 (https=)
CA (1) CA2731438C (https=)
WO (1) WO2010017500A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481041B2 (en) 2005-04-06 2013-07-09 Ibc Pharmaceuticals, Inc. Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
RU2012148816A (ru) * 2010-05-07 2014-06-20 Ф. Хоффманн-Ля Рош Аг Метод диагностики для определения клеток ex vivo
EP2635300A4 (en) * 2010-11-03 2014-04-02 Ibc Pharmaceuticals Inc DOCK-AND-LOCK (DNL) CONSTRUCTS FOR THERAPY AGAINST HUMAN IMMUNE WEAKAGE VIRUS (HIV)
AU2011336396B2 (en) * 2010-12-02 2016-02-04 Immunomedics, Inc. In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
CN102485753A (zh) * 2010-12-03 2012-06-06 上海杰隆生物工程股份有限公司 具有人血管内皮生长因子结合活性的人源重链可变区
KR102009932B1 (ko) * 2011-11-15 2019-08-12 퀸시 바이오사이언스 엘엘씨 허혈로 인한 뉴런 손상을 감소시키기 위한 아포에쿼린
SI2900277T1 (sl) * 2012-12-13 2022-05-31 Immunomedics, Inc. Odmerki imunokonjugatov protiteles in SN-38 za boljšo učinkovitost in zmanjšano toksičnost
CA2899811A1 (en) * 2013-04-01 2014-10-09 Immunomedics, Inc. Anti-mucin antibodies for early detection and treament of pancreatic cancer
EP2981281B1 (en) * 2013-04-03 2020-07-15 IBC Pharmaceuticals, Inc. Combination therapy for inducing immune response to disease
CN105829893A (zh) * 2013-06-14 2016-08-03 西班牙格拉纳达大学 用于胰腺癌诊断及治疗响应的生物标记物
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
CA2948013A1 (en) * 2014-06-30 2016-01-07 Immunomedics, Inc. Antibodies reactive with an epitope located in the n-terminal region of muc5ac comprising cysteine-rich subdomain 2 (cys2)
KR20160045547A (ko) * 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
CN104974988B (zh) * 2015-07-31 2016-08-24 南京麦科林生物医药科技有限公司 抗胰腺癌单克隆抗体及其应用
EP3773670A4 (en) * 2018-04-05 2022-03-09 Tarveda Therapeutics, Inc. Hsp90-targeting conjugates and formulations thereof
SG11202102416SA (en) 2018-09-10 2021-04-29 Cold Spring Harbor Laboratory Methods for treating pancreatitis
JP7036996B2 (ja) * 2019-10-18 2022-03-15 日本メジフィジックス株式会社 Ｒｉ標識されたヒト化抗体
US11857803B2 (en) * 2020-12-16 2024-01-02 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy with enhanced beta treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6357596A (ja) * 1986-08-29 1988-03-12 Nisshin Flour Milling Co Ltd モノクロ−ナル抗体、その製法およびそれからなる肝疾患診断剤
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US7282567B2 (en) * 2002-06-14 2007-10-16 Immunomedics, Inc. Monoclonal antibody hPAM4
AU2006232310B9 (en) * 2005-04-06 2011-07-21 Ibc Pharmaceuticals, Inc. Improved stably tethered structures of defined compositions with multiple functions or binding specificities
WO2008088658A2 (en) * 2007-01-17 2008-07-24 Immunomedics, Inc. Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites

Similar Documents

Publication Publication Date Title
JP2011530536A5 (https=)
ES2994774T3 (en) Methods for preventing or treating allergy by administering an il-4r antagonist
TWI856945B (zh) 用抗tslp抗體治療氣喘
US20200399384A1 (en) Method of treating diseases using an il-17 receptor antibody formulation
US8846002B2 (en) Anti-CD74 immunoconjugates and methods of use
JP2020188775A (ja) プロラクチン受容体結合タンパク質およびそれらの使用
KR101927118B1 (ko) Ｇｄ２ 양성암의 치료 방법
ES2547689T3 (es) Composiciones y métodos para el tratamiento de enfermedades y trastornos asociados con la señalización de citocinas que implican anticuerpos que se unen a IL-22 y a IL-22R
JP2024150445A5 (https=)
JP2009538284A5 (https=)
RU2005100777A (ru) Моноклональное антитело рам4 и его применение для диагностики и лечения рака поджелудочной железы
JP2008520551A5 (https=)
JP2006502698A5 (https=)
JP6596014B2 (ja) 爪および頭皮乾癬の治療方法
AU2020266593B2 (en) Methods for treating or preventing asthma by administering an IL-33 antagonist
JPWO2018191479A5 (https=)
EP4166159A1 (en) Pharmaceutical composition of anti-il-17a antibodies and use thereof
JP2026505129A (ja) 抗ｃｄｈ１７抗体及びその使用
CN120958023A (zh) 通过阻断il-13和tslp治疗哮喘
KR20160072268A (ko) 항-efna4 항체-약물 접합체
TW202104266A (zh) 使用抗ｐｓｍａ／ｃｄ３抗體來治療腎癌之方法
Desai et al. Biologics in asthma: emerging biologics
US20210230265A1 (en) Methods for treating copd by administering an il-33 antagonist
CN115969986A (zh) 羟丙基β环糊精稳定MMAE类抗体药物偶联物制剂的应用
CN110582702A (zh) 使用il-17拮抗剂选择性治疗哮喘的方法